To ask the Minister for the Cabinet Office, with reference to the Infected Blood Compensation Scheme, if he will review the supplementary route for people for whom the impact of their viruses and their treatments are not fully captured by the core route tariff.

The Infected Blood Inquiry Response Expert Group provided advice on the design of infection severity bands for the core route. They considered the health impacts and treatments that applicants are likely to have experienced. This includes many side effects of treatments, including interferon, and conditions such as chronic fatigue. The core route tariffs therefore already take into account conditions that infected people are likely to experience as a result of their infection or treatment.

The supplementary route, as set out in the Infected Blood Compensation Scheme Regulations 2025, provides additional awards for applicants whose circumstances necessitate a higher compensation payment. As a result, the eligibility criteria for the Severe Health Condition award reflects the conditions and impacts the Expert Group identified as not being addressed in other aspects of the scheme, including the core route or Exceptional Loss award.